Position in XENE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,789,879
New position
Shares Held
99,568
first reported quarter
Ownership
0.103%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 76.19717178209868.ToString("F0")%
Shared 0.ToString("F0")%
None 23.802828217901332.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026AXIOM INVESTORS LLC /DE holds $88,046,456 across 7 Biotechnology names. XENE ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
239,447 | $39,154,373 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
199,988 | $14,851,108 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
56,529 | $9,554,531 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
85,475 | $9,009,065 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
91,749 | $7,979,410 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
99,568 | $5,789,879 | |
| 7 | VOR |
Vor Biopharma Inc.
|
95,745 | $1,708,090 |
All Filings in XENE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,789,879 | 99,568 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||